Related Experiment Video

Updated: Apr 28, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.1K

Network of microRNAs-mRNAs interactions in pancreatic cancer

Elnaz Naderi1, Mehdi Mostafaei2, Akram Pourshams1

  • 1Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Biomed Research International
|June 5, 2014
PubMed
Abstract

Insights

This study maps microRNA-mRNA interactions in pancreatic cancer, identifying miR-24 as a key regulator. This network analysis aids in understanding pancreatic cancer and developing new therapeutic strategies.

Area of Science:

  • Genomics
  • Molecular Biology
  • Oncology

Background:

  • MicroRNAs (miRNAs) are small RNA molecules regulating gene expression.
  • miRNAs play a significant role in human cancer development.
  • Pancreatic cancer is the fourth leading cause of cancer-related mortality.

Purpose of the Study:

  • To construct a comprehensive network of miRNA-mRNA interactions in pancreatic cancer.
  • To identify key regulatory miRNAs and their target genes involved in pancreatic cancer.

Main Methods:

  • Utilized data from 56 exclusively expressed miRNAs and 1176 downregulated genes in pancreatic cancer.
  • Analyzed miRNA-mRNA interactions and networks using MAGIA and Cytoscape 3 software.
  • Performed functional annotation of candidate genes using DAVID annotation tool.

Main Results:

  • Developed a network comprising 217 mRNA nodes, 15 miRNA nodes, and 241 regulatory edges.
  • Identified miR-24 as the most potent miRNA, regulating numerous critical genes.
  • Found ACVR2B, GFRA1, and MTHFR among the significant downregulated target genes.

Conclusions:

  • This is the first study to simultaneously analyze miRNA-mRNA interactions in pancreatic cancer.
  • The constructed network can validate experimental findings and refine miRNA target predictions.
  • This network provides a foundation for developing novel therapeutic approaches for pancreatic cancer.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.3K
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

24.0K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.0K
MicroRNAs01:22

MicroRNAs

9.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K